Additional file 1: of Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial

Autor: BjøRn Madsen, Jonel Trebicka, Thiele, Maja, Israelsen, Mads, Manimozhiyan Arumugan, Havelund, Troels, Krag, Aleksander

SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documents. (DOC 121 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=sygma_______::ea87b2ebd51230d52dea4e8deff44a28
https://doi.org/10.6084/m9.figshare.5927761

Enprostil And Ranitidine In Prevention Of Duodenal Ulcer Relapse: One Year Double Blind Comparative Trial

Autor: Lauritsen, Karsten, Havelund, Troels, Laursen, Laurits Stærk, Bytzer, Peter, Kjærgaard, Johan, Rask-Madsen, Jørgen

Publikováno v: British Medical Journal (Clinical Research Edition), 1987 Apr 01. 294(6577), 932-934.

Externí odkaz: https://www.jstor.org/stable/29526656

Mastocytosis

Autor: Broesby-Olsen, Sigurd, Kristensen, Thomas Kielsgaard, Agertoft, Lone, Møller, Michael Boe, Hermann, Pernille, Torfing, Trine, Havelund, Troels, Mørtz, Charlotte G, Bindslev-Jensen, Carsten, Vestergaard, Hanne

Publikováno v: Broesby-Olsen, S, Kristensen, T K, Agertoft, L, Møller, M B, Hermann, P, Torfing, T, Havelund, T, Mørtz, C G, Bindslev-Jensen, C & Vestergaard, H 2016, ' Mastocytose ', Ugeskrift for Laeger, bind 178, nr. 15, V10150854, s. 1426-1430 . < http://ugeskriftet.dk.proxy1-bib.sdu.dk:2048/videnskab/mastocytose >

Mastocytosis is a heterogeneous disease with an increased number and activation of mast cells. Subtypes range from benign to rare aggressive forms, and the disease may affect people of all ages. The pathogenesis involves mutations in the KIT gene in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::bbc3ae79a18b600133db4daece25ba49
http://ugeskriftet.dk/videnskab/mastocytose

Behandling af paracetamolforgiftning - en ny guideline

Autor: Dalhoff, Kim, Andersen, Jesper, Clemmensen, Otto, Hansen, Jesper Bach, Havelund, Troels, Jørgensen, Marianne Hørby, Ott, Peter, Rolff, Hans Christian, Schmidt, Lars Ebbe

Publikováno v: Dalhoff, K, Andersen, J, Clemmensen, O, Hansen, J B, Havelund, T, Jørgensen, M H, Ott, P, Rolff, H C & Schmidt, L E 2013, ' Behandling af paracetamolforgiftning-en ny guideline ', Rationel Farmakoterapi, bind 2013, nr. 2 . < http://www.irf.dk/dk/publikationer/rationel_farmakoterapi/maanedsblad/2013/maanedsblad_nr_2_februar_2013.htm >

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b6029d53d56991243145433611f64b35
https://vbn.aau.dk/da/publications/2c82a086-015d-4e0c-80eb-4010ac2ae216

Barrett's esophagus. Diagnosis, follow-up and treatment

Autor: Bremholm, Lasse, Funch-Jensen, Peter, Eriksen, Jan, Hendel, Lene, Havelund, Troels, Matzen, Peter

Publikováno v: Bremholm, L, Funch-Jensen, P, Eriksen, J, Hendel, L, Havelund, T & Matzen, P 2012, ' Barrett's esophagus. Diagnosis, follow-up and treatment ', Danish Medical Journal, vol. 59, no. 8, pp. C4499 .

Barrett's Esophagus (BE) is a premalignant condition in the esophagus. Esophageal adenocarcinomas have the fastest increase of incidence of all solid tumors in the western world. BE is defined as areas with macroscopic visible columnar epithelium and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e34af17273f71a9f78e85191eb456bca
https://pure.au.dk/portal/da/publications/barretts-esophagus-diagnosis-followup-and-treatment(9d132f3e-1dd2-4a0f-bc25-d619b667170e).html